Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: A European MCL intergroup study

1. Pott, C.
2. Hoster, E.
3. Delfau-Larue, M.-H.
4. Beldjord, K.
5. Böttcher, S.
6. Asnafi, V.
7. Plonquet, A.
8. Siebert, R.
9. Callet-Bauchu, E.
10. Andersen, N.
11. Van Dongen, J.J.M.
12. Klapper, W.
13. Berger, F.
14. Ribrag, V.
15. Van Hoof, A.L.
16. Trneny, M.
17. Walewski, J.
18. Dreger, P.
19. Unterhalt, M.
20. Hiddemann, W.
21. Kneba, M.
22. Kluin-Nelemans, H.C.
23. Hermine, O.
24. Macintyre, E.
25. Dreyling, M.